Tag Archive for: ai in healthcare

Beyond AlphaFold: AI Is Starting to Design New Biology

AlphaFold transformed biology by predicting the three-dimensional structures of proteins. A new system called AlphaProtein Novo takes a very different step: instead of predicting proteins that already exist, it attempts to design entirely new enzymes with functions requested by researchers. The system uses machine learning to build both protein structure and amino-acid sequence around a […]

Can AI Help Men Avoid ADT? The ASTuTE Trial is Testing That Question

A prospective clinical trial is testing whether artificial intelligence can help determine which men with intermediate-risk prostate cancer really need short-term androgen deprivation therapy alongside radiotherapy. The ASTuTE study uses the ArteraAI Prostate Test, which analyses digitised biopsy images together with clinical information to estimate both the risk of future metastasis and the likelihood that […]

Reprogramming Cancer, Decoding DNA: Two Promising New Frontiers in Cancer Research

Two important scientific developments, published last week, offer a glimpse of where prostate cancer research could be heading, even though both remain firmly in the experimental or preclinical arena. The first comes from Adelaide University, where researchers have developed “smart” lipid nanoparticles designed to reprogramme tumour-associated macrophages, immune cells that cancers can exploit to suppress […]

Genetic Maps of Blood Proteins Open New Paths for Cancer Drug Repurposing

A huge international team has just completed the largest study ever on how our genes control the levels of proteins circulating in our blood. The work, led by researchers at Queen Mary University of London and the Berlin Institute of Health, brings together data from more than 78,000 people across 38 cohorts worldwide and has […]

AlphaGenome: a New AI Tool to Understand DNA

Imagine you have a long string of DNA code, a million letters long. A new AI tool called AlphaGenome reads that code and predicts exactly what it does. It tells you how active genes are, how DNA folds open or closed, where proteins stick to it, and even how far-apart parts of DNA touch each […]

A New AI Tool Speeds Up Drug Discovery for Cancer and Beyond

Researchers at Tsinghua University in China have created DrugCLIP, an AI system that finds potential new medicines millions of times faster than old methods. Traditional drug discovery uses slow computer simulations to check if a small molecule fits into a protein’s binding pocket, the spot where drugs attach to block or change a protein’s action […]

From T Cells to B Cells: The Next Generation of Personalized Cancer Vaccines

A research team at the Korea Advanced Institute of Science and Technology (KAIST) has developed a new artificial intelligence model that could change how personalized cancer vaccines are designed. For decades, most cancer vaccine strategies have focused on training the immune system’s T cells to attack tumors quickly and directly, which can shrink tumors but […]

AI Developed ISM3830 a New CBLB Inhibitor

Insilico Medicine has nominated ISM3830, a potentially best-in-class oral CBLB inhibitor discovered through its proprietary Chemistry42 AI platform, as a preclinical candidate for advanced cancer immunotherapy. This novel molecule targets Casitas B-lineage lymphoma-b (CBLB), an intracellular E3 ubiquitin ligase that acts as a master negative regulator of T-cell and natural killer (NK) cell activation, distinct […]

Beyond the Primary Target: How DeepTarget Rewrites Mechanism Discovery in Cancer

The modern small‑molecule rarely acts through a single, invariant target, and DeepTarget is a new computational framework that embraces this reality by mapping both direct and indirect anti‑cancer mechanisms across diverse cellular contexts. Developed by researchers at Sanford Burnham Prebys and collaborators, DeepTarget integrates large‑scale drug viability screens, genome‑wide CRISPR knockout data, and matched omics […]

ESMO Congress 2025 Confirms the Role of AI in Cancer Treatment

At the ESMO Congress 2025 held in Berlin, artificial intelligence demonstrated a pivotal role in reshaping cancer treatment through novel biomarker applications. Studies presented at this event showed how AI models analyzing pathology images, imaging data, and genomic profiles can improve predictions of patient responses to therapies. For example, in metastatic colorectal cancer, AI identified […]